INTERPACE BIOSCIENCES, INC. (IDXG) › Cost of RevenueINTERPACE BIOSCIENCES, INC. (IDXG) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2014: $1.27M2015: $6.91M2016: $6.64M2017: $7.36M2018: $10.20M2019: $15.89M2020: $21.67M2021: $14.31M2022: $13.61M2023: $14.98M2024: $17.00M2025: $14.60M$14.60M2014Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$14.60M-14.1%2024$17.00M+13.5%2023$14.98M+10.1%2022$13.61M-4.9%2021$14.31M-34.0%2020$21.67M+36.4%2019$15.89M+55.8%2018$10.20M+38.6%2017$7.36M+10.8%2016$6.64M-3.9%2015$6.91M+445.0%2014$1.27M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share